Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO Pre-Tax Margin

Income before tax as a percentage of revenue.

Medical Facilities CorporationTSX: DR.TO

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin widens to 26.0%

Pre-tax margin was 26.0% in Q1 FY2026, up 15.4 pp from a year earlier. On a trailing-twelve-month basis it was 18.4%, up 1.7 pp year over year. Over 3 fiscal years it widened by 11.5 pp.

Context

  • Pre-tax margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
26.0%+11.5 pp QoQ
Last fiscal yearDec 2025
15.6%+0.2 pp YoY
LTMMar 2026
18.4%+1.7 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+15.4 pp——
1 year+0.2 pp——
3 years+11.5 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
15.6%
Year-over-year change
+0.2pp

Pre-Tax Margin vs competitors

How DR.TO compares with its peers on the latest reported figures

  • DR.TO's LTM Mar 2026 pre-tax margin of 18.4% is the 2nd highest of the 8 companies compared; the peer median is -14.2%.
  • Its year-over-year change of +1.7 pp is the 7th highest of 8, against a peer median of +19.4 pp.
  • Over three fiscal years its change of +11.5 pp compares with a peer median of +164.0 pp.
DR.TO Competitors Peer median
Pre-Tax Margin for DR.TO and competitors
Company Period LTM level YoY 3-year change
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202620.2% +9.7 pp+166.0 pp
DR.TOMedical Facilities CorporationLTM Mar 202618.4% +1.7 pp+11.5 pp
TSND.TOTerrAscend Corp.LTM Mar 20262.1% +19.4 pp+127.1 pp
CRRX.TOCareRx CorporationLTM Mar 20261.3% +2.3 pp+10.3 pp
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-14.2% -22.9 pp—
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-17.2% +28.3 pp+1523.3 pp
WEED.TOCanopy Growth CorporationLTM Mar 2026-84.7% +137.2 pp+833.7 pp
PRN.TOProfound Medical Corp.LTM Mar 2026-205.7% +78.2 pp+161.9 pp
EPRX.TOEupraxia Pharmaceuticals Inc.FY2025— ——
Peer median (excluding DR.TO) -14.2%+19.4 pp+164.0 pp

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue398.63M424.55M445.58M331.53M258.62M
Cost of Revenue130.03M143.93M148.9M111.65M160.42M
Gross Profit268.61M280.63M296.68M219.88M98.2M
Gross Margin67.4%66.1%66.6%66.3%38.0%
Research & Development00000
Selling, General & Admin177.58M198.21M151.73M151.12M119.23M
Operating Expenses191.25M245.69M229.57M158.24M50.72M
Depreciation & Amortization26.77M20.76M21.54M19.37M11.94M
EBITDA103.4M51.15M72.43M82.57M59.41M
EBITDA Margin25.9%12.0%16.3%24.9%23.0%
Operating Income77.36M34.94M67.11M61.64M47.47M
Operating Margin19.4%8.2%15.1%18.6%18.4%
Interest Income76K8.54M717K1.87M2.24M
Interest Expense25.74M12.89M16.5M12.09M3.59M
Other Income / Expenses(26.47M)(17.44M)(14.27M)(10.53M)(7.19M)
Income Before Tax50.89M17.5M52.32M51.11M40.28M
Pre-Tax Margin12.8%4.1%11.7%15.4%15.6%
Income Tax Expense4.4M5.21M8.33M(5.69M)5.06M
Net Income15.5M(4.41M)18.5M73.49M21.08M
Net Margin3.9%-1.0%4.2%22.2%8.2%
EPS (Basic)1.500.420.731.031.09
EPS (Diluted)1.490.420.731.031.09
Weighted Avg Shares31.09M29.37M25.35M18.5M19.48M
Weighted Avg Shares (Diluted)31.13M29.37M25.25M24M19.48M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.